Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Aclaris Triples After Progress in Rheumatoid Arthritis Drug Trial
By Dan Weil
Jan 19, 2021 4:34 PM EST
PRESS RELEASES
Aclaris Announces Pricing Of Public Offering Of Common Stock
By GlobeNewswire
Jan 20, 2021 8:45 AM EST
INVESTING
Aclaris Triples After Progress in Rheumatoid Arthritis Drug Trial
By Dan Weil
Jan 19, 2021 4:34 PM EST
INVESTING
General Motors, AMC, Roku: 5 Top Stock Gainers for Tuesday
By Rob Lenihan
Jan 19, 2021 4:23 PM EST
PRESS RELEASES
Aclaris Announces Proposed Public Offering Of Common Stock
By GlobeNewswire
Jan 19, 2021 4:01 PM EST
PRESS RELEASES
Aclaris Therapeutics Announces Positive Preliminary Topline Data From 12-Week Phase 2a Trial Of Oral ATI-450 For Moderate To Severe Rheumatoid Arthritis
By GlobeNewswire
Jan 19, 2021 7:00 AM EST
PRESS RELEASES
Aclaris Therapeutics To Participate In The Evercore ISI 3rd Annual HealthCONx Conference
By GlobeNewswire
Nov 16, 2020 4:01 PM EST
PRESS RELEASES
Aclaris Therapeutics To Present At Upcoming Investor Conferences
By GlobeNewswire
Sep 1, 2020 4:01 PM EDT
PRESS RELEASES
Aclaris Therapeutics Supports Investigator-Initiated Clinical Trial Of ATI-450 For Cytokine Release Syndrome In Hospitalized Patients With COVID-19
By GlobeNewswire
Jun 17, 2020 7:01 AM EDT
PRESS RELEASES
Aclaris Therapeutics Announces Publication Of An Abstract Of The Phase 1 Clinical Trial Results For ATI-450, An Investigational Compound, At The EULAR 2020 E-Congress
By GlobeNewswire
Jun 3, 2020 7:00 AM EDT
PRESS RELEASES
Aclaris Therapeutics To Present At The Jefferies Virtual Healthcare Conference
By GlobeNewswire
May 26, 2020 4:01 PM EDT
PRESS RELEASES
Aclaris Therapeutics Secures $11 Million Term Loan Facility
By GlobeNewswire
Mar 31, 2020 4:01 PM EDT
PRESS RELEASES
Aclaris Therapeutics To Announce Fourth Quarter And Full Year 2019 Financial Results On February 25, 2020
By GlobeNewswire
Feb 19, 2020 5:00 PM EST
PRESS RELEASES
Aclaris Therapeutics To Present At The SVB Leerink 9th Annual Global Healthcare Conference
By GlobeNewswire
Feb 10, 2020 7:00 AM EST
STOCKS
Skin lesion drug only scratches the surface, says Aclaris CEO
By Gregg Greenberg
Feb 6, 2017 2:01 PM EST
VIDEO
New Skin Lesion Drug Only Scratches Market's Surface, Says Aclaris CEO
By Gregg Greenberg
Feb 6, 2017 12:04 PM EST
OPINION
5 Stocks With Big Insider Buying -- Should You Love Them Too?
By Roberto Pedone
Nov 4, 2015 10:39 AM EST
OPINION
5 Stocks Insiders Love Right Now
By Roberto Pedone
Oct 21, 2015 10:53 AM EDT
JIM CRAMER
Jim Cramer's 'Mad Money' Recap: Watching China Warily, Again
By Scott Rutt
Oct 7, 2015 8:08 PM EDT
